Supplier of Generic and Off-Patent Brand Medications

The contract seeks a supplier to provide cost-effective generic equivalents or off-patent branded medications to serve as comparators in clinical trials, ensuring regulatory compliance and scientific validity in pharmaceutical research. These medications must meet stringent quality, stability, and sourcing standards to support FDA-regulated studies, with an emphasis on reliability, consistency, and timely delivery to meet trial timelines. The supplier is expected to maintain robust inventory management, regulatory documentation, and chain-of-custody protocols to ensure product integrity throughout the supply chain. This subcontract is issued under the Department of Health and Human Services, specifically through the FDA Office of Acquisition and Grant Services, with a NAICS code of 325412 indicating pharmaceutical manufacturing. The opportunity was posted on May 4, 2026, and responses are due by May 15, 2026, at 6:00 PM Eastern Time. No set-aside designation is specified, meaning all eligible suppliers may compete. The place of performance and point of contact details are not provided, and the contract will be managed through the SAM.gov platform, where full solicitation details can be accessed.